Amadeus Capital Partners and Archimedia Investments are backing web-based medical practice management company Qinec.
The transaction sees £1.6 million worth of early-stage capital provided to Qinec in the hope that it can build its team and bolster its core market product offerings.
Qinec works by streamlining processes such as appointment booking, patient record-keeping, prescribing and billing. It operates through a cloud-hosted software platform, available to ‘every class’ of outpatient care provider such as doctors, ophthalmologists and physiotherapists.
The investment marks the latest in a line of medical technology outlays made by Amadeus. Its portfolio also includes Glysure, an Oxfordshire-based glucose monitory technology; ophthalmological screening company Optos; and clinical trials recruitment platform TrialReach.
Qinec CEO Robbie Hughes says that the company’s goal is to ’empower’ a broad base of clinicians with the management platform they need.
‘A significant opportunity exists to transform the economics of healthcare if outpatient care provision can be delivered in a joined-up and connected way,’ he adds.
Amadeus Capital Partners is a technology venture capital firm with £500 million under management, while Archimedia also focuses on the tech sector as well as operating in the consumer area.
Alex van Someran, Amadeus Seed Fund managing partner, comments, ‘The medical IT sector is undergoing rapid and significant change; companies offering cost-effective products that benefit both the professionals and the patients will quickly build market share.’
